Literature DB >> 11124905

Crystal structure of an enzyme-substrate complex provides insight into the interaction between human arylsulfatase A and its substrates during catalysis.

R von Bülow1, B Schmidt, T Dierks, K von Figura, I Usón.   

Abstract

Arylsulfatase A (ASA) belongs to the sulfatase family whose members carry a C(alpha)-formylglycine that is post-translationally generated by oxidation of a conserved cysteine or serine residue. The crystal structures of two arylsulfatases, ASA and ASB, and kinetic studies on ASA mutants led to different proposals for the catalytic mechanism in the hydrolysis of sulfate esters. The structures of two ASA mutants that lack the functional C(alpha)-formylglycine residue 69, in complex with a synthetic substrate, have been determined in order to unravel the reaction mechanism. The crystal structure of the inactive mutant C69A-ASA in complex with p-nitrocatechol sulfate (pNCS) mimics a reaction intermediate during sulfate ester hydrolysis by the active enzyme, without the covalent bond to the key side-chain FGly69. The structure shows that the side-chains of lysine 123, lysine 302, serine 150, histidine 229, the main-chain of the key residue 69 and the divalent cation in the active center are involved in sulfate binding. It is proposed that histidine 229 protonates the leaving alcoholate after hydrolysis.C69S-ASA is able to bind covalently to the substrate and hydrolyze it, but is unable to release the resulting sulfate. Nevertheless, the resulting sulfation is low. The structure of C69S-ASA shows the serine side-chain in a single conformation, turned away from the position a substrate occupies in the complex. This suggests that the double conformation observed in the structure of wild-type ASA is more likely to correspond to a formylglycine hydrate than to a twofold disordered aldehyde oxo group, and accounts for the relative inertness of the C69S-ASA mutant. In the C69S-ASA-pNCS complex, the substrate occupies the same position as in the C69A-ASA-pNCS complex, which corresponds to the non-covalently bonded substrate. Based on the structural data, a detailed mechanism for sulfate ester cleavage is proposed, involving an aldehyde hydrate as the functional group. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11124905     DOI: 10.1006/jmbi.2000.4297

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  21 in total

1.  Structure of a lipid A phosphoethanolamine transferase suggests how conformational changes govern substrate binding.

Authors:  Anandhi Anandan; Genevieve L Evans; Karmen Condic-Jurkic; Megan L O'Mara; Constance M John; Nancy J Phillips; Gary A Jarvis; Siobhan S Wills; Keith A Stubbs; Isabel Moraes; Charlene M Kahler; Alice Vrielink
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-13       Impact factor: 11.205

2.  Synthesis and evaluation of general mechanism-based inhibitors of sulfatases based on (difluoro)methyl phenyl sulfate and cyclic phenyl sulfamate motifs.

Authors:  Sarah R Hanson; Lisa J Whalen; Chi-Huey Wong
Journal:  Bioorg Med Chem       Date:  2006-10-11       Impact factor: 3.641

3.  Metachromatic leukodystrophy: Biochemical characterization of two (p.307Glu→Lys, p.318Trp→Cys) arylsulfatase A mutations.

Authors:  Adem Özkan; Hatice Asuman Özkara
Journal:  Intractable Rare Dis Res       Date:  2016-11

Review 4.  A review of coumarin derivatives in pharmacotherapy of breast cancer.

Authors:  Musiliyu A Musa; John S Cooperwood; M Omar F Khan
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

5.  Interaction of arylsulfatase-A (ASA) with its natural sulfoglycolipid substrates: a computational and site-directed mutagenesis study.

Authors:  Matthias Schenk; Chaitanya A K Koppisetty; Daniela Costa Santos; Euridice Carmona; Smita Bhatia; Per-Georg Nyholm; Nongnuj Tanphaichitr
Journal:  Glycoconj J       Date:  2009-11       Impact factor: 2.916

6.  Role of heparan sulfatases in ovarian and breast cancer.

Authors:  Ashwani Khurana; Daniah Beleford; Xiaoping He; Jeremy Chien; Viji Shridhar
Journal:  Am J Cancer Res       Date:  2013-01-18       Impact factor: 6.166

Review 7.  Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets.

Authors:  Jin-Ping Lai; James R Thompson; Dalbir S Sandhu; Lewis R Roberts
Journal:  Future Oncol       Date:  2008-12       Impact factor: 3.404

8.  Overexpression of inactive arylsulphatase mutants and in vitro activation by light-dependent oxidation with vanadate.

Authors:  Terri M Christianson; Chris M Starr; Todd C Zankel
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

9.  Arylsulfatase K, a novel lysosomal sulfatase.

Authors:  Elena Marie Wiegmann; Eva Westendorf; Ina Kalus; Thomas H Pringle; Torben Lübke; Thomas Dierks
Journal:  J Biol Chem       Date:  2013-08-28       Impact factor: 5.157

10.  Characterization of glycosaminoglycan (GAG) sulfatases from the human gut symbiont Bacteroides thetaiotaomicron reveals the first GAG-specific bacterial endosulfatase.

Authors:  Jonathan E Ulmer; Eric Morssing Vilén; Ramesh Babu Namburi; Alhosna Benjdia; Julie Beneteau; Annie Malleron; David Bonnaffé; Pierre-Alexandre Driguez; Karine Descroix; Gilbert Lassalle; Christine Le Narvor; Corine Sandström; Dorothe Spillmann; Olivier Berteau
Journal:  J Biol Chem       Date:  2014-07-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.